Logan Edmonds, DO
Internal Medicine · Somerset, KYNPI 1821483298
Payments from drug & device makers
Across 147 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$369
- Novo Nordisk$322
- Pfizer$215
- Vanda Pharmaceuticals Inc.$180
- GSK$148
- Otsuka America Pharmaceutical, Inc.$126
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,690100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $369 |
| Novo Nordisk | 17 | $322 |
| Pfizer | 13 | $215 |
| Vanda Pharmaceuticals Inc. | 7 | $180 |
| GSK | 9 | $148 |
| Otsuka America Pharmaceutical, Inc. | 6 | $126 |
| Boehringer Ingelheim | 7 | $117 |
| Lilly USA, LLC | 5 | $104 |
| Phathom Pharmaceuticals, Inc. | 6 | $96 |
| AstraZeneca | 6 | $91 |
| Shield Therapeutics Inc | 1 | $90 |
| Amgen | 4 | $88 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Sanofi-aventis U.S. LLC | 3 | $64 |
| Insulet Corporation | 3 | $57 |
| Novartis | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Almatica Pharma LLC | 2 | $46 |
| Lundbeck LLC | 3 | $45 |
| Ardelyx, Inc. | 2 | $44 |
| Bayer | 2 | $38 |
| Corcept Therapeutics | 2 | $35 |
| Johnson & Johnson | 1 | $28 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
How this compares
$2,690 in reported general payments places this provider in the 80th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 12 | $153,955 |
| JardianceEmpagliflozin | 57 | $41,605 |
| EliquisApixaban | 49 | $36,869 |
| OzempicSemaglutide | 27 | $32,897 |
| JanuviaSitagliptin Phosphate | 24 | $22,288 |
| TrulicityDulaglutide | 19 | $22,283 |
| MounjaroTirzepatide | 20 | $20,981 |
| LinzessLinaclotide | 11 | $8,065 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,084 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $6,000 |
| Dexlansoprazole DrDexlansoprazole | 11 | $1,878 |
| Doxycycline Hyclate | 28 | $1,071 |
| Levothyroxine Sodium | 111 | $982 |
| Gabapentin | 53 | $727 |
| Ondansetron OdtOndansetron | 37 | $715 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Jardiance, Spiriva Respimat | $117 | $201,64481 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $104 | $43,26439 claims |
| PfizerEliquis | $215 | $36,86949 claims |
| Novo NordiskOzempic | $322 | $32,89727 claims |
| MerckJanuvia | $16 | $22,28824 claims |
| AbbVieLinzess | $369 | $8,06511 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $14 | $982111 claims |
| Almatica Pharma LLCSertraline Hcl | $46 | $26140 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Somerset
- Mark AdamsLondon$15.4M
- Matthew WenkerErlanger$12.8M
- Jason ChesneyLouisville$6.3M
- Neil FarrisLexington$3M
- David JohnsonOwensboro$787K
- Hollis ClarkMurray$780K
- Fares KhaterWhitesburg$412K
- Christopher PhillipsPaducah$315K
- Cynthia Bowman-StroudPaducah$234K
- Bernard BuchananOwensboro$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.